PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
04-Feb-2020 Investis Digital Announces Launch of Patient Recruitment Practice Investis Digital
04-Feb-2020 Food Industry Expert Joins Benson Hill as General Counsel Benson Hill
04-Feb-2020 New Center for Indigenous Cancer Research at Roswell Park Has Regional Focus, Global Reach Roswell Park Comprehensive Cancer Center
04-Feb-2020 CNS Pharmaceuticals Announces Completion of GMP Manufacturing CNS Pharmaceuticals, Inc.
04-Feb-2020 Study Published in Nature Communications Highlights the Role of the Epichaperome in Protein Connectivity-based Dysfunction in Alzheimer's Disease Samus Therapeutics, Inc.
04-Feb-2020 Synthetic Biologics to Present at the 2020 BIO CEO & Investor Conference Synthetic Biologics, Inc.
04-Feb-2020 CollPlant Launches New Corporate Website to Showcase Recent Developments in Core Business Segments CollPlant
04-Feb-2020 Leap Therapeutics to Present at 22nd Annual BIO CEO & Investor Conference Leap Therapeutics, Inc.
03-Feb-2020 Neurocrine Biosciences Announces Appointment of Shalini Sharp to Board of Directors Neurocrine Biosciences, Inc.
03-Feb-2020 FDA and FTC Announce New Efforts to Further Deter Anti-Competitive Business Practices, Support Competitive Market for Biological Products to Help Americans U.S. Food and Drug Administration
03-Feb-2020 Inceptua appoints new Head of Asia-Pacific, Clinical Trial Services Inceptua
03-Feb-2020 Applied Photophysics board appoints Tim Flanagan as CEO Applied Photophysics
03-Feb-2020 Truvian Sciences Appoints Shane Bowen, Ph.D. as Senior Vice President of Engineering Truvian Sciences
03-Feb-2020 United Therapeutics Announces Study of Unituxin® (dinutuximab) for Small Cell Lung Cancer Did Not Meet Primary Endpoint United Therapeutics Corporation
03-Feb-2020 Hypha Discovery and Cypex announce a partnership to expand client access to drug metabolites Sciad Communications Ltd
03-Feb-2020 Envision Pharma Group kick off 2020 by scooping a triple win at the PM Society Awards Envision Pharma Group
03-Feb-2020 GSK announces European Medicines Agency (EMA) accepted marketing authorisation application for belantamab mafodotin for the treatment of relapsed or refractory multiple myeloma GlaxoSmithKline plc
03-Feb-2020 GSK announces European Medicines Agency (EMA) accepted marketing authorisation application for belantamab mafodotin for the treatment of relapsed or refractory multiple myeloma GlaxoSmithKline plc
02-Feb-2020 Oxford Nanopore Sequencers Have Left UK for China, to Support Rapid, Near-sample Coronavirus Sequencing for Outbreak Surveillance Oxford Nanopore Technologies
01-Feb-2020 MYM Subsidiary, Sublime Culture Inc., Receives Cannabis Cultivation License From Health Canada MYM Nutraceuticals Inc.